Search Results

You are looking at 1-4 of 4

Recurrent Stroke Risk in Pilots with Atrial Fibrillation
Jessica Tedford,
Valerie Skaggs,
Ann Norris,
Farhad Sahiar, and
Charles Mathers
Article Category: Research Article
Volume/Issue: Volume 91: Issue 4
Online Publication Date: Apr 01, 2020
DOI: 10.3357/AMHP.5326.2020
Page Range: 352 – 357

Download PDF
James R. DeVollM.D., M.P.H.
Article Category: Research Article
Volume/Issue: Volume 93: Issue 5
Online Publication Date: May 01, 2022
Page Range: 405 – 405

-catheter aortic valve replacement (TAVR) was developed for high-risk patients and is rapidly becoming the procedure of choice (e.g., Mick Jagger). Treatment of atrial fibrillation has been revolutionized by the advances in cardiac electrophysiology to map and perform highly focused ablation of foci of abnormal rhythms. Guidelines are well supported for medications for rhythm control and structural heart disease, anticoagulation, and procedures or devices to reduce thrombus formation in the atrial appendage (e.g., Watchman device). Over the next decade, we will

Sophie Levasseur,
Nina Purvis,
Sophia Trozzo,
Seok Hoon Chung,
Matthew Ades, and
Laura M. Drudi
Article Category: Review Article
Volume/Issue: Volume 95: Issue 1
Online Publication Date: Jan 01, 2024
Page Range: 45 – 53

pathway by inducing the expression of tissue factor, mainly found on monocytes. 55 Interestingly, proinflammatory cytokine levels remained elevated in patients despite halting anticoagulation therapy. Further, high levels of IL-6 sustained after VTE have been correlated to post-disease complications. 53 , 54 Often referred to as the “messenger cytokine”, IL-6 activates many proteins involved in the thrombosis pathway, such as fibrinogen. 60 Studies have been able to correlate IL-6 plasma levels to cases of VTE. 46 Further research is necessary to understand the

Victor Schneider,
Bette Siegel, and
John R. Allen
Article Category: Research Article
Volume/Issue: Volume 94: Issue 8
Online Publication Date: Aug 01, 2023
Page Range: 634 – 643

thrombosis occurred on the ISS, one of which was found in real time, resulting in concurrent anticoagulation therapy. 1 , 26 Findings included stagnant and reversed jugular blood flow in 6 out of 11 crewmembers studied. 26 Possible mechanisms for the development of SANS and a neck deep vein thrombosis are currently not known, but could include chronic partial intracranium/neck outflow obstruction due to loss of hydrostatic forces, which induces a headward fluid shift, or other possible small secondary increases in intracranial pressure. It is also